Acromegaly treatment has greatly evolved in recent decades, but there are still patients whose acromegaly is not controlled with currently available treatments, and there is a need to improve the treatment burden. Fortunately, there are new treatments under development that may increase treatment efficacy and convenience.
Keywords: GH receptor antagonist; acromegaly; new drugs; octreotide SC depot; paltusotine; somatostatin receptor ligands.
© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.